1W50
Apo Structure of BACE (Beta Secretase)
Summary for 1W50
Entry DOI | 10.2210/pdb1w50/pdb |
Related | 1FKN 1M4H 1PY1 1SGZ 1UJJ 1UJK 1W51 |
Descriptor | BETA-SECRETASE 1, IODIDE ION (3 entities in total) |
Functional Keywords | alternative splicing, alzheimer's disease, aspartic protease, aspartyl protease, base, beta-secretase, glycoprotein, hydrolase, memapsin 2, transmembrane, zymogen |
Biological source | HOMO SAPIENS (HUMAN) |
Cellular location | Membrane; Single-pass type I membrane protein: P56817 |
Total number of polymer chains | 1 |
Total formula weight | 46330.06 |
Authors | Patel, S.,Vuillard, L.,Cleasby, A.,Murray, C.W.,Yon, J. (deposition date: 2004-08-04, release date: 2004-09-23, Last modification date: 2023-12-13) |
Primary citation | Patel, S.,Vuillard, L.,Cleasby, A.,Murray, C.W.,Yon, J. Apo and Inhibitor Complex Structures of Bace (Beta-Secretase) J.Mol.Biol., 343:407-, 2004 Cited by PubMed Abstract: Human BACE, also known as beta-secretase, shows promise as a potential therapeutic target for Alzheimer's disease. We determined the apo structure of BACE to 1.75 A, and a structure of a hydroxyethylamine inhibitor complex derived by soaking. These show significant active-site movements compared to previously described BACE structures. Additionally, the structures reveal two pockets that could be targeted by structure-based drug design. PubMed: 15451669DOI: 10.1016/J.JMB.2004.08.018 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.75 Å) |
Structure validation
Download full validation report